• Replimune will hold its annual stockholder meeting virtually on Sept. 15, 2026.
• Key vote seeks to double authorized common shares to 300,000,000 from 150,000,000, increasing total authorized capital stock to 310,000,000 shares.
• Other items include a non-binding advisory vote on named executive officer pay for the year ended March 31, 2026.
• Stockholders will also vote on ratifying PricewaterhouseCoopers as independent auditor for the fiscal year ending March 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-087650), on July 29, 2026, and is solely responsible for the information contained therein.